R-LD | P-LD | R-Halo | P-Halo | R-Pl | P-Pl | ANOVA | |
---|---|---|---|---|---|---|---|
Baseline 1 | |||||||
RT | 317 ± 14 | 333 ± 17 | 352 ± 10 | 350 ± 11 | 387 ± 29 | 333 ± 13 | F(5,90) = 2.01, p = 0.085, η2 = 0.100 |
MT | 286 ± 14 | 261 ± 10 | 303 ± 6 | 269 ± 8 | 278 ± 13 | 278 ± 11 | F(5,90) = 1.76, p = 0.129, η2 = 0.089 |
AD | -0.7 ± 0.3 | -1.5 ± 0.5 | -0.9 ± 0.4 | -1.2 ± 0.3 | -1.2 ± 0.5 | -0.9 ± 0.2 | F(5,90) = 0.64, p = 0.670, η2 = 0.034 |
Baseline 2 | |||||||
RT | 305 ± 22 | 318 ± 18 | 346 ± 9 | 353 ± 10 | 374 ± 30 | 287 ± 14 | F(5,90) = 3.07, p = 0.013, η2 = 0.146 |
MT | 249 ± 8 | 259 ± 14 | 269 ± 7 | 269 ± 6 | 255 ± 11 | 237 ± 7 | F(5,90) = 0.71, p = 0.140, η2 = 0.087 |
AD | -0.7 ± 0.3 | -0.4 ± 0.5 | -0.3 ± 0.5 | -0.9 ± 0.3 | -1.2 ± 0.2 | -0.9 ± 0.3 | F(5,90) = 0.78, p = 0.569, η2 = 0.041 |
Adaptation | |||||||
RT | 298 ± 21 | 327 ± 17 | 343 ± 8 | 368 ± 15 | 371 ± 25 | 321 ± 23 | Fb : F(1,90) = 0.005, p = 0.941, η2 = 0.0 D : F(2,90) = 2.74, p = 0.070, η2 = 0.06 Fb*D : F(2,90) = 2.69, p = 0.073, η2 = 0.06 |
MT | 243 ± 6 | 264 ± 15 | 277 ± 11 | 279 ± 7 | 270 ± 15 | 264 ± 13 | Fb : F(1,90) = 0.32, p = 0.573, η2 = 0.004 D : F(2,90) = 2.23, p = 0.114, η2 = 0.05 Fb*D : F(2,90) = 0.69, p = 0.502, η2 = 0.01 |
Retention | |||||||
RT | 292 ± 24 | 288 ± 14 | 351 ± 8 | 348 ± 10 | 338 ± 23 | 289 ± 12 | Fb : F(1,90) = 2.01, p = 0.160, η2 = 0.02 D : F(2,90) = 6.78, p = 0.002, η2 = 0.13 Fb*D : F(2,90) = 1.31, p = 0.276, η2 = 0.03 |
MT | 227 ± 8 | 232 ± 14 | 262 ± 7 | 250 ± 6 | 245 ± 10 | 231 ± 9 | Fb : F(1,90) = 0.87, p = 0.353, η2 = 0.01 D : F(2,90) = 3.92, p = 0.023, η2 = 0.08 Fb*D : F(2,90) = 0.59, p = 0.554, η2 = 0.01 |
Values depict the mean ± SEM by averaging over consecutive epochs for each participant and group. A one-way ANOVA was used to compare mean values across groups during baseline 1 and baseline 2. A multifactorial ANOVA was used to compare mean values across groups, with feedback (reward*punishment) and drug (LD*haloperidol*placebo) as between-groups factors. R-LD, n = 16; P-LD, n = 16; R-Halo, n = 16; P-Halo, n = 16; R-Pl, n = 16; P-Pl, n = 16; RT, in ms; MT, in ms; AD, °; Fb, feedback; D, drug. Significant results are bold.